首页 正文

Solid tumor rejection using personalized incompatible human leukocyte antigen (HLA) and blood group ABH antigens

{{output}}
Cancer immunotherapies have become mainstream, targeting tumor elimination via various mechanisms, albeit with varied effectiveness. Here, we review briefly the current landscape of cancer immunotherapies and the central role of human leukocyte antigen (HLA) i... ...